MYCIO Wealth Partners’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-120
Closed -$5K 356
2016
Q3
$5K Hold
120
﹤0.01% 662
2016
Q2
$4K Sell
120
-84
-41% -$2.87K ﹤0.01% 708
2016
Q1
$6K Sell
204
-2,916
-93% -$80.5K ﹤0.01% 580
2015
Q4
$82K Sell
3,120
-120
-4% -$3.12K 0.01% 237
2015
Q3
$77K Sell
3,240
-138
-4% -$3.33K 0.02% 241
2015
Q2
$80K Sell
3,378
-42
-1% -$948 0.02% 244
2015
Q1
$81K Buy
3,420
+1,716
+101% +$38.5K 0.02% 236
2014
Q4
$36K Buy
1,704
+1,452
+576% +$29.2K 0.01% 308
2014
Q3
$4K Buy
+252
New +$3.98K ﹤0.01% 534
2014
Q1
Sell
-1,200
Closed -$13K 630
2013
Q4
$13K Buy
+1,200
New +$13.5K ﹤0.01% 414

Other funds holding EW

MYCIO Wealth Partners's EW Position: Q4 2016 in Review

MYCIO Wealth Partners sold out of Edwards Lifesciences (EW) in Q4 2016, closing a stake of 120 shares — an estimated $5K sold.

MYCIO Wealth Partners first reported a position in EW in Q4 2013 and held it in 10 quarters. The position peaked at $82K in Q4 2015. 686 funds tracked by Wall St. Rank hold EW as of Q4 2016.

  • MYCIO Wealth Partners reported no remaining Edwards Lifesciences position as of Q4 2016 after selling out during the quarter.
  • MYCIO Wealth Partners sold 120 Edwards Lifesciences shares in Q4 2016, an estimated $5K.
  • MYCIO Wealth Partners first reported a position in Edwards Lifesciences in Q4 2013 and held it in 10 quarters.
  • MYCIO Wealth Partners's Edwards Lifesciences position peaked at $82K in Q4 2015.
  • 686 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2016.

Based on MYCIO Wealth Partners's 13F filing for Q4 2016, filed 1 Feb 2017.